Gelteq Limited Ordinary Shares (GELS) Stock Ticker
Market factors today
Unlock the full GELS picture
About Gelteq Limited Ordinary Shares
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
GELS stock facts
| Ticker symbol | GELS |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market cap | $5.0M |
| CEO | Nathan Jacob Givoni |
| Employees | 18 |
| Headquarters | Clayton, VIC, AU |
| IPO date | 2024-10-29 |
| Website | www.gelteq.com |
What you can see for GELS on Tickr
Live GELS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GELS report.
Rankings
FAQ
What is the ticker symbol for Gelteq Limited Ordinary Shares?
The ticker symbol for Gelteq Limited Ordinary Shares is GELS, listed on the NASDAQ Global Select.
What is GELS?
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including…